Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Levothyroxine or minimally invasive therapies for benign thyroid nodules.

ABSTRACT:

SUBMITTER: Bandeira-Echtler E

PROVIDER: S-EPMC9039971 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Levothyroxine or minimally invasive therapies for benign thyroid nodules.

Bandeira-Echtler Elizabeth E Bergerhoff Karla K Richter Bernd B

The Cochrane database of systematic reviews 20140618 6

<h4>Background</h4>Thyroid nodules (TN) are common in the adult population. Some physicians use suppressive levothyroxine (LT4) therapy to achieve a reduction in the number and volume of TN. In addition, minimally invasive treatments, such as percutaneous ethanol injection (PEI) sclerotherapy, laser photocoagulation (LP), and microwave (MW), radiofrequency (RF) and high-intensity focused ultrasound (HIFU) ablation, have been proposed, especially for pressure symptoms and cosmetic complaints, as ...[more]

PMID: 24941398

Similar Datasets

Current and emerging mechanical minimally invasive therapies for benign prostatic obstruction.

Project description: Not available

| S-EPMC6376539 | biostudies-literature

Image-guided thermal ablation of benign thyroid nodules.

Project description: Not available

| S-EPMC5698193 | biostudies-literature

Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology

Project description:BACKGROUND: Following fine needle aspiration, 15-30% of thyroid nodules are not clearly benign or malignant. These cytologically indeterminate nodules are often referred for diagnostic surgery, though most prove benign. A novel diagnostic test measuring the expression of 167 genes has shown promise in improving pre-operative risk assessment. We evaluated this test in a prospective, multicenter study. METHODS: Over 19 months, we performed a prospective study at 49 clinical sites enrolling 3,789 patients and collecting 4,812 samples from thyroid nodules >1cm requiring evaluation. We obtained 577 cytologically indeterminate aspirates with corresponding histopathology of excised lesions on 413. Central blinded histopathologic review served as the reference (“gold”) standard. After applying inclusion criteria, gene expression classifier results were obtained for 265 indeterminate nodules used in this analysis, and performance was calculated. RESULTS: 85 of 265 indeterminate nodules were malignant. The gene expression classifier correctly identified 78 of 85 as ‘suspicious’ (92% sensitivity, [84%-97%] 95% CI). Specificity was 52%, [44%-59%]. The negative predictive value was 95%, 94%, and 85%, respectively, for aspirates with AUS/FLUS, FN/SFN, or ‘suspicious’ cytology. Analysis of 7 false negative cases revealed 6 with a paucity of thyroid follicular cells, suggesting that insufficient sampling of the nodule had occurred. CONCLUSIONS: Though individualized clinical care is recommended, these data support consideration of a conservative approach for most patients with indeterminate FNA cytology and benign gene expression classifier results.

2012-06-25 | GSE34289 | GEO

Comparative urine proteomic study involving papillary thyroid carcinoma and benign thyroid nodules.

Project description: Not available

| S-EPMC12011787 | biostudies-literature

Stages of benign thyroid nodules: principles and ultrasound signs

Project description: Not available

| S-EPMC11320486 | biostudies-literature

Thyroid artery embolization of large solitary symptomatic benign thyroid nodules through transradial approach.

Project description: Not available

| S-EPMC10423340 | biostudies-literature

Update on minimally invasive surgery and benign prostatic hyperplasia.

Project description: Not available